DYADIC INTERNATIONAL INC Remaining Share Repurchase Authorization
DYADIC INTERNATIONAL INC (DYAI) had Remaining Share Repurchase Authorization of $2.16 million as of 2018-08-31, per its 10-K filed 2020-03-30.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2020-03-30
- 2018-08-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $2.16M.
- 2018-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $4.09M.
- 2018-01-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $4.23M.
- 2017-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $4.46M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2018-08-31 | $2.16M 10-K · filed 2020-03-30 |
| 2018-03-31 | $4.09M 10-K · filed 2019-03-27 |
| 2018-01-31 | $4.23M 10-K · filed 2019-03-27 |
| 2017-12-31 | $4.46M 10-K · filed 2020-03-30 |
| 2017-08-16 | $5.00M 10-K · filed 2020-03-30 |
| 2017-02-28 | $2.55M 10-K · filed 2020-03-30 |
| 2017-01-31 | $3.21M 10-K · filed 2019-03-27 |
| 2016-12-31 | $4.60M 10-K · filed 2019-03-27 |
| 2016-02-16 | $15.00M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |